SBIR/STTR Research Award

THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO ESTABLISH A STABLE SOURCE OF WELL-CHARACTERIZED ANTIBODIES TO DNA ADDUCTS OF CARCINOGENS/MUTAGENS, SO THAT THESE IMPORTANT PROBES CAN BE MADE AVAILABLE FOR RESEARCH INTO MECHANISM(S) OF CARCINOGENESIS, AND

Award identifier 698740599d4bea4ace248303e96d78f3ffca7164298e4767ec91fb2af914f443Awarding agency Department of Health and Human Services

Award amount

$47,507

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Biological Research Faculty &
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO ESTABLISH A STABLE SOURCE OF WELL-CHARACTERIZED ANTIBODIES TO DNA ADDUCTS OF CARCINOGENS/MUTAGENS, SO THAT THESE IMPORTANT PROBES CAN BE MADE AVAILABLE FOR RESEARCH INTO MECHANISM(S) OF CARCINOGENESIS, AND FOR MOLECULAR CANCER EPIDEMIOLOGY TO MONITOR HUMAN POPULATIONS FOR POSSIBLE EXPOSURE TO ENVIRONMENTAL CARCINOGENS. PHASE I EFFORTS INVOLVE: A.PRODUCTION OF DNA ADDUCTED WITH DIFFERENT LEVELS OF THE ANTI ISOMER, 1,2-DIOL-3,4-EPOXIDE, ONE OF THE ULTIMATE CARCINOGENIC METABOLITES OF THE ENVIRONMENTAL CARCINOGEN, 5-METHYLCHRYSENE (ACHIEVED BY TREATING CALF THYMUS DNA UNDER DIFFERENT CONDITIONS IN VITRO) TO BE USED AS A HAPTEN FOR THE IMMUNOGEN AND AS THE SOLID PHASE IN ENZYME-LINKED IMMUNOSORBENT ASSAYS. B.UTILIZATION OF DIFFERENT IMMUNIZATION METHODS (IN VITRO AND INTRASPLENIC, IN ADDITION TO CONVENTIONAL IN VIVO METHODS) SO THAT THE AMOUNT OF IMMUNOGEN NEEDED COULD BE REDUCED, HENCE HELPING IN THE PRODUCTION OF A VARIETY OF MONOCLONAL AND/OR ""DEFINED'' POLYCLONAL ANTIBODIES. DURING PHASE I, RABBIT ANTISERA WILL BE RAISED AGAINST THE DNA ADDUCTED WITH 5-METHYLCHRYSENE, IN ADDITION TO MONOCLONALS THAT CAN DETECT SOME OF THESE LESIONS IN DNA. SUCCESS IN THESE ENDEAVORS WILL ENSURE THE FEASIBILITY OF THE OVERALL PROGRAM AND PAVE THE WAY FOR DEVELOPMENTAL STUDIES OF PHASE II, AS WELL AS TO THE EVENTUAL PRODUCTION OF ASSAY KITS FOR DETERMINING SUCH

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.